Rankings
▼
Calendar
EVAX FY 2022 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena
EVAX
Evaxion Biotech A/S
$20M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$25M
Net Income
-$23M
EPS (Diluted)
$-39.20
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$942,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$14M
Stockholders' Equity
$8M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$25M
-$26M
+2.2%
Net Income
-$23M
-$25M
+5.6%
← Q4 2021
All Quarters
Q1 2022 →